CTKB vs TFX · rev $92.3M vs P/E 2083, rev $1.12B
Cytek Biosciences Inc (CTKB) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported CTKB revenue for 2026-06-30 was $92.3M. Net income was -$31.0M. CTKB currently screens at market cap $421.8M.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
CTKB currently screens at market cap $421.8M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the CTKB and TFX stock pages for the full models.
Not investment advice.